Senior Research Scientist

The petition was approved based on the petitioner's documented extraordinary ability in AI, supported by peer-reviewed publications and three patent applications. Evidence of 30 citations from independent researchers worldwide demonstrated the international reach and adoption of his findings. Additionally, his critical role as a CEO and his peer-review activity satisfied the O-1A criteria.

The approval was based on the petitioner's record of 5 peer-reviewed journal articles and 2 preprints in highly ranked journals. He demonstrated sustained acclaim through 54 citations, including a paper in the top 10% of its field, and 12 completed peer reviews for prestigious venues. Additionally, the petition showed major research funding and significant contributions to drug sensitivity prediction and robotic navigation.

The approval was based on the petitioner's record of 4 peer-reviewed journal articles and 5 preprints in top-tier venues, which garnered 38 citations. He also demonstrated expertise through 5 completed peer reviews for elite conferences. His development of the BOLT deep learning framework and novel genomic data sampling algorithms satisfied the criteria for original contributions of major significance.

The petition was approved based on a strong record of 7 peer-reviewed publications in top-tier venues like CVPR and ICCV, alongside 286 citations. The petitioner met the O-1A criteria through extensive peer review invitations for journals like IEEE T-PAMI and leadership roles in industry-standard benchmarking challenges. Evidence of international research funding from the European Research Council further solidified the claim of extraordinary ability.